Literature DB >> 11063096

Molecular biology of degenerative disc disease.

B H Guiot1, R G Fessler.   

Abstract

The intervertebral disc is a complex anatomic and biochemical structure. It is composed primarily of fibrocytes and chondrocytes that are anatomically segregated in an elaborate avascular macromolecular matrix of collagen and proteoglycans. Degenerative processes associated with aging and trauma result in morphological and molecular changes to the disc. Morphological changes are observed as dehydration, fissuring, and tearing of the nucleus, annulus and endplates. On the molecular level, degenerative changes include decreased diffusion, decreased cell viability, decreased proteoglycan synthesis, and alteration in collagen distribution. The role of inflammatory mediators in these processes, and the potential use of growth factors to delay or reverse the degenerative cascade, is poorly understood. However, these areas are under active investigation, the results of which may soon contribute significantly to our understanding of degenerative disc disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11063096     DOI: 10.1097/00006123-200011000-00003

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  32 in total

1.  A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration.

Authors:  Christine L Le Maitre; Anthony J Freemont; Judith A Hoyland
Journal:  Int J Exp Pathol       Date:  2006-02       Impact factor: 1.925

2.  Effect of compression and anisotropy on the diffusion of glucose in annulus fibrosus.

Authors:  Alicia R Jackson; Tai-Yi Yuan; Chun-Yuh C Huang; Francesco Travascio; Wei Yong Gu
Journal:  Spine (Phila Pa 1976)       Date:  2008-01-01       Impact factor: 3.468

3.  Methods to monitor distribution and metabolic activity of mesenchymal stem cells following in vivo injection into nucleotomized porcine intervertebral discs.

Authors:  G W Omlor; H Bertram; K Kleinschmidt; J Fischer; K Brohm; T Guehring; M Anton; Wiltrud Richter
Journal:  Eur Spine J       Date:  2009-12-29       Impact factor: 3.134

4.  Spinal hernia tissue autofluorescence spectrum.

Authors:  Darius Varanius; Gunaras Terbetas; Juozas V Vaitkus; Aurelija Vaitkuviene
Journal:  Lasers Med Sci       Date:  2012-03-03       Impact factor: 3.161

5.  Short-term follow-up of disc cell therapy in a porcine nucleotomy model with an albumin-hyaluronan hydrogel: in vivo and in vitro results of metabolic disc cell activity and implant distribution.

Authors:  G W Omlor; J Fischer; K Kleinschmitt; K Benz; J Holschbach; K Brohm; M Anton; T Guehring; W Richter
Journal:  Eur Spine J       Date:  2014-05-07       Impact factor: 3.134

6.  Analysis of the impact of the course of hydration on the mechanical properties of the annulus fibrosus of the intervertebral disc.

Authors:  Małgorzata Żak; Celina Pezowicz
Journal:  Eur Spine J       Date:  2016-07-13       Impact factor: 3.134

Review 7.  Molecular therapy of the intervertebral disc.

Authors:  S Tim Yoon; Nilpesh M Patel
Journal:  Eur Spine J       Date:  2006-07-12       Impact factor: 3.134

8.  Potential use of Sox9 gene therapy for intervertebral degenerative disc disease.

Authors:  Ronjon Paul; Rex C Haydon; Hongwei Cheng; Akira Ishikawa; Nikola Nenadovich; Wei Jiang; Lan Zhou; Benjamin Breyer; Tao Feng; Purnendu Gupta; Tong-Chuan He; Frank M Phillips
Journal:  Spine (Phila Pa 1976)       Date:  2003-04-15       Impact factor: 3.468

9.  A conductivity approach to measuring fixed charge density in intervertebral disc tissue.

Authors:  Alicia R Jackson; Tai-Yi Yuan; Chun-Yuh Huang; Wei Yong Gu
Journal:  Ann Biomed Eng       Date:  2009-09-11       Impact factor: 3.934

10.  Critical early roles for col27a1a and col27a1b in zebrafish notochord morphogenesis, vertebral mineralization and post-embryonic axial growth.

Authors:  Helena E Christiansen; Michael R Lang; James M Pace; David M Parichy
Journal:  PLoS One       Date:  2009-12-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.